Abstract:Colorectal cancer (CRC) is among the most widely spread cancers globally. Aberrant alternative polyadenylation (APA) plays a role in cancer onset and its progression. Consequently, this study focused on highlighting the role of APA events and signals in the prognosis of patients with CRC. The APA events, RNA sequencing (RNA-seq), somatic mutations, copy number variants (CNVs), and clinical information of the CRC cohort were obtained from The Cancer Genome Atlas (TCGA) database and UCSC (University of California-Santa Cruz) Xena database. The whole set was sorted into two sets: a training set and a test set in a ratio of 7:3. 197 prognosis-related APA events were collected by performing univariate Cox regression signature in patients with CRC. Subsequently, a signature for APA events was established by least absolute shrinkage and selection operator (LASSO) and multivariate Cox analysis. The risk scores were measured for individual patients on the basis of the signature and patients were sorted into two groups; the high-risk group and the low-risk group as per their median risk scores. Kaplan-Meier curves, principal component analysis (PCA), and time-dependent receiver operator characteristic (ROC) curves revealed that the signature was able to predict patient prognosis effectively and further validation was provided in the test set and the whole set. The high-risk and low-risk groups displayed various distributions of mutations and CNVs. Tumor mutation burden (TMB) alone and in combination with the signature predicted the prognosis of CRC patients, but the gene frequencies of TMBs and CNVs did not change in the low- and high-risk groups. Moreover, immunotherapy and chemotherapy treatments showed different responses to PD-1 inhibitors and multiple chemotherapeutic agents in the low and high-risk groups based on the tumor immune dysfunction and exclusion (TIDE) and genomics of drugs sensitivity in cancer (GDSC) databases. This study may help in understanding the potential roles of APA in CRC, and the signature for prognosis-related APA events can work as a potential predictor for survival and treatment in patients with CRC.

Alternative Polyadenylation alters UBASH3B-ZNF652 competition to involve in Triple-Negative Breast Cancer

RNA-sequencing and Microarray Data Mining Revealing: the Aberrantly Expressed Mrnas Were Related with a Poor Outcome in the Triple Negative Breast Cancer Patients

Dissecting the Heterogeneity of the Alternative Polyadenylation Profiles in Triple-Negative Breast Cancers.

The role of alternative polyadenylation in breast cancer

Comprehensive Analysis of Alternative Polyadenylation Regulators Concerning CD276 and Immune Infiltration in Bladder Cancer

Alternative Polyadenylation of Mrna and Its Role in Cancer

Large-scale alternative polyadenylation-wide association studies to identify putative cancer susceptibility genes

Alternative Polyadenylation: Methods, Mechanism, Function, and Role in Cancer.

Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer

Genome-wide Profiling of Polyadenylation Sites Reveals a Link Between Selective Polyadenylation and Cancer Metastasis

Alternative Polyadenylation Associated with Prognosis and Therapy in Colorectal Cancer.

The role of alternative polyadenylation in epithelial-mesenchymal transition of non-small cell lung cancer

Large-scale alternative polyadenylation (APA)-wide association studies to identify putative susceptibility genes in human common cancers

Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma

Alternative Polyadenylation in Glioblastoma Multiforme and Changes in Predicted RNA Binding Protein Profiles.

Aberrant Ki‐67 Expression Through 3′UTR Alternative Polyadenylation in Breast Cancers

Relationship between NUDT21 mediated alternative polyadenylation process and tumor

Crosstalk among Alternative Polyadenylation, Genetic Variants and Ubiquitin Modification Contribute to Lung Adenocarcinoma Risk

Alternative Polyadenylation Modification Patterns Reveal Essential Posttranscription Regulatory Mechanisms of Tumorigenesis in Multiple Tumor Types.

A Ten N6-methyladenosine-related Long Non-Coding RNAs Signature Predicts Prognosis of Triple-Negative Breast Cancer

Genetic variants that impact alternative polyadenylation in cancer represent candidate causal risk loci